Pediatric Multiple Sclerosis
7
0
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program
Exercise Training in Pediatric-Onset Multiple Sclerosis Patients
Mobile Attentional Bias Modification Training in Pediatric MS
Cognitive Dysfunction in MS: Using Altered Brain Oscillation to Link Molecular Mechanisms With Clinical Outcomes
Sleep, Physical Activity and Multiple Sclerosis Symptoms in Pediatric Multiple Sclerosis
ATOMIC (Active Teens With MultIple sClerosis) Teens: A Feasibility Study
Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis